Law360, New York (November 4, 2014, 3:38 PM EST) -- The U.S. Food and Drug Administration will require stronger warnings regarding risks associated with Nexium, Prilosec and other popular heartburn drugs, concluding that doctors and patients should know more about potential drug interactions and side effects.
The agency’s action was disclosed Friday in response to a 2011 petition from nonprofit group Public Citizen Inc., which sued the FDA in April in hopes of forcing regulators to address the petition’s concerns. Although Public Citizen’s petition was granted in several respects, the FDA also shot down portions calling for black box warnings, instead confining new risks to standard labeling sections.
On Monday, Public...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!